The invention relates to methods for preventing, slowing the progression of, delaying or treating metabolic disorders induced in patients by the treatment with neuroleptic agents comprising administering to the patients an SGLT2 inhibitor.本發明係關於預防、減緩進展、延遲或治療患者因使用精神安定劑(neuroleptic agents)治療而誘發之代謝障礙之方法,其包含投與該等患者SGLT2抑制劑。